Scholars Central

Conference abstractPublished 18 Oct 2017

Erythropoietin level and left ventricular dysfunction in patients on chronic hemodialysis

Authors: Slobodan Davinic

General Hospital Leskovac, Serbia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic renal failure leads to hypo-regenerative anemia due to erythropoietin (EPO) deficiency, but endogenous EPO is increased in patients with left ventricular dysfunction (LVD). Previous only a few-scale data addressed the clinical and prognostic value of EPO levels in relation to LVD in patients on chronic hemodialysis (HD). This study aimed to investigate the serum EPO levels in the context of LVD in chronic HD patients. We studied 71 patients on chronic HD without adult cystic kidney disease, renal cancer, other malignancies, active hepatitis or primary lung disease, divided in group A with left ventricular ejection fraction (LVEF) 50% 52 patients and group C all investigated 71 patients. The serum EPO, brain natriuretic peptide (BNP), C-reactive protein (CRP) levels and echocardiographic parameters were measured. Group A and group B were comparable in regard the serum hemoglobin, urea, creatinine, CRP levels, hematocrit, doses of recombinant human EPO, duration of HD (p>0.05). The serum EPO and BNP levels in group A were significantly higher than that in group B (Z=-4.99, p<0.001, Z=-3.1, p<0.01, respectivly). In group A we found a significant positive correlation between the serum EPO and BNP levels (rs=0.67, p<0.05), but no in group B. Between LVEF and the serum EPO and BNP levels we no found correlation in group A and group B, but in group C exists clearly negative correlation between LVEF and the serum EPO and BNP levels (rs=-0.36, p<0.05, rs=-0.67, p<0.001, respectively). Between the serum CRP and EPO and BNP levels, we no found any correlation in all groups. In conclusion, chronic HD patients with LVD have higher serum EPO levels than that without LVD. Thus, EPO may serve as an important serum biomarker for discrimination of LVD in chronic HD patients. In general population, elevated serum EPO levels are associated with an impaired prognosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nephrology & Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nephrology & Therapeutics
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Slobodan Davinic”